Association of < em > STAT3, CYP3A5 < /em > , and < em > ABCG2 < /em > Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients
CONCLUSION: STAT3 -1697C>G may be a novel risk factor for osimertinib-induced paronychia in patients with NSCLC.PMID:36974789 | DOI:10.21873/anticanres.16331
Source: Cell Research - Category: Cytology Authors: Masaaki Tanda Kazuhiro Yamamoto Tomoki Hori Hiroki Nishiguchi Miki Yagi Michiko Shimizu Toru Konishi Tomonori Ozaki Natsue Yoshioka Motoko Tachihara Takefumi Ito Shigeki Ikushima Tomohiro Omura Ikuko Yano Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Study